Alcolase
Develops an enzyme-based treatment for alcohol intolerance, backed by early-stage investors to advance its therapeutic approach.
Overview
Alcolase is developing an enzyme treatment aimed at alcohol intolerance, positioning the company in biotechnology rather than core AI. Its work targets people affected by alcohol intolerance and focuses on a therapeutic approach based on enzyme activity. The company raised about $2 million across one undisclosed round, described as a €1.5 million financing backed by Ada Ventures and Antler. The capital is intended to support development of its enzyme treatment.
Funding History
Ada Ventures, Antler back Alcolase in €1.5M round to develop enzyme treatment for alcohol intolerance
Frequently Asked Questions
- How much has Alcolase raised in total?
- Alcolase has raised a total of $2M across 1 funding round.
- Who are Alcolase's investors?
- Alcolase's investors include Antler, Ada Ventures, Delphinus Venture Capital, Manigoff Invest.
- What does Alcolase do?
- Alcolase is developing an enzyme treatment aimed at alcohol intolerance, positioning the company in biotechnology rather than core AI. Its work targets people affected by alcohol intolerance and focuses on a therapeutic approach based on enzyme activity. The company raised about $2 million across one undisclosed round, described as a €1.5 million financing backed by Ada Ventures and Antler. The capital is intended to support development of its enzyme treatment.
- Where is Alcolase headquartered?
- Alcolase is headquartered in San Francisco, CA.
Investors
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.